In the field of biopharmaceuticals, non-clinical data, including data from single and repeat-dose toxicity, genotoxicity, carcinogenicity, reproductive juvenile toxicity, local tolerance, and more, is an essential and valuable resource for drug development. However, efficiently parsing this vast amount of data and making informed decisions based on it has always posed a challenge for the industry. The introduction of two tools, SEND Explorer and Pinnacle 21 Enterprise, has revolutionized data intelligence in this field. SEND Explorer, a data visualization tool with more than 15 years of experience in non-clinical data research, simplifies access non-clinical data and presents it in intuitive charts and graphs that are both user-friendly and scientifically meaningful. With SEND Explorer, researchers can easily gain a deeper understanding of data patterns and trends, uncover the key information hidden behind the data, and make data-driven R&D strategies and decisions with increased confidence. Pinnacle 21 Enterprise(P21E), a professional CDISC compliance validation and problem-solving tool, ensures CDISC compliance of SEND datasets, as well as the clinical datasets (SDTM, ADaM), providing a powerful tool for drug development and marketing.
The webinar will include:
Explore how to utilize interactive analytics software SEND Explorer to graphically present non-clinical study results and uncover patterns and trends inherent in the data, thereby facilitating rapid internal decision-making. Discover how to leverage Pinnacle 21 Enterprise to validate CDISC compliance and efficiently address the issues. The following topics will be covered:
- Single-study visualization
- Multi-study visualization
- Publication-quality images generation
- Data Sharing and highly efficient collaboration
- CDISC compliance validation and issues management (SEND, SDTM, ADaM)
- Define.xml and Reviewer’s Guides creation
For whom the webinar will be beneficial the most:
- Toxicologists
- Clinical Pathologist
- Project Director
- Statisticians and Programmers
- Drug Development Team
